Newsroom
Sorted by: Latest
-
Andau Medical and IDS Spa Announce Strategic Partnership to Bring BlancOne®’s Breakthrough Approach to Professional Whitening to the U.S. Market
EDMONTON, Alberta--(BUSINESS WIRE)--Andau Medical Inc., a market leader for advanced dental technologies and solutions, including Admetec Ergonomic Loupes & Lights, is proud to announce a strategic partnership and exclusive distributorship for BlancOne®, an innovative professional whitening technology transforming how dental practices deliver whitening and generate new revenue streams. This partnership brings BlancOne®’s patented Click+™ technology to dental professionals across the U.S., p...
-
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in the following upcoming investor conferences: H.C. Wainwright 28th Annual Global Healthcare Conference, September 14-16, 2026 Format: Fireside chat and one-on-one meetings Presentation Date & Time...
-
State of AI Report: Only One-Third of Enterprises Using AI Are Putting Agents to Work
BOSTON--(BUSINESS WIRE)--Tempo Software’s 2026 State of AI in Portfolio Management Report finds that only 33% of enterprises using AI are actually delegating tasks to agents....
-
AFS Announces Acquisition of Debticate
EXTON, Pa. & BOSTON--(BUSINESS WIRE)--AFS announces its acquisition of Debticate...
-
JBC Technologies Acquires NADCO Tapes and Labels
NORTH RIDGEVILLE, Ohio--(BUSINESS WIRE)--JBC Technologies acquires NADCO Tapes & Labels, expanding its U.S. footprint and specialty converting capabilities across core markets nationwide....
-
IMU Biosciences and Eurofins Transplant Genomics Form Strategic Partnership to Advance Transplant-Related Clinical Development Programmes
LONDON--(BUSINESS WIRE)--IMU Biosciences, a biotechnology company using its High Definition (“HD”) Immunology™ platform to decode the immune system and transform how we understand, diagnose, and treat disease, and Eurofins Transplant Genomics, a leading provider of laboratory services focused on post-transplant monitoring, today announced a licensing agreement that gives Eurofins Transplant Genomics exclusive access to IMU’s proprietary HD Immunology platform for transplant-related clinical dev...
-
Pathlight Learning Acquires Four Primrose Schools in Omaha, Signs Agreement to Develop 11 More
CHICAGO--(BUSINESS WIRE)--Pathlight Learning (“Pathlight”), a leading franchisee of Primrose Schools® (“Primrose”) and a portfolio company of Taurus Capital Partners (“Taurus”), today announced the acquisition of four Primrose schools in Omaha, Nebraska. The company also announced an 11-school development agreement with Primrose, under which Pathlight will build and open new schools across several markets in the coming years, expanding access to high-quality early education and care and helping...
-
Cimpress to Host Virtual Investor Day on September 30, 2026
DUNDALK, Ireland--(BUSINESS WIRE)--Cimpress plc (Nasdaq: CMPR) will host its 2026 annual Investor Day on Wednesday, September 30, 2026 from 8:00 am ET to 11:00 am ET. Investors can access the virtual, live video event from Cimpress’ investor relations website at ir.cimpress.com. The event will feature presentations from executives across Cimpress highlighting the company’s progress against our strategic goals and financial priorities, as well as panel discussions covering topics including how m...
-
Inkit Introduces New Product Updates to Simplify Document Management and Team Collaboration
ST. PAUL, Minn.--(BUSINESS WIRE)--Inkit announced three new product enhancements designed to simplify document management, improve teamwork, and give teams more control over workflows....
-
Palladius Capital Management Deploys ~$475M in First Half of 2026
AUSTIN, Texas--(BUSINESS WIRE)--Palladius Capital Management (“Palladius”), a vertically-integrated real estate investment manager with both credit and equity investment strategies, today announced that in the first half of 2026 it deployed approximately $475 million across its affiliated platforms, highlighting investment activity, platform expansion, and strategic execution. Palladius deployed capital spanning SFR & commercial credit executions, student housing, small-bay industrial, buil...